Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitisStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: 5 February 2025
Depemokimab for treating chronic rhinosinusitis with nasal polyps TSID 12012Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Electrosurgery (diathermy and coblation) for tonsillectomy, (IP324/2)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
Pharyngeal electrical stimulation for neurogenic dysphagia (IPG781)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 January 2024
Sirolimus for treating facial angiofibroma caused by tuberous sclerosis complex in people 6 years and over (terminated appraisal) (TA972)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 May 2024
Sirolimus for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older [ID6440]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 9 July 2024
Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over [ID6391]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC